Genovese Burford & Brothers Wealth & Retirement Plan Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,692
Closed -$120K 190
2018
Q2
$120K Buy
1,692
+83
+5% +$5.86K 0.04% 110
2018
Q1
$121K Buy
+1,609
New +$128K 0.04% 110
2017
Q4
Sell
-529
Closed -$42K 318
2017
Q3
$42K Buy
529
+238
+82% +$18.2K 0.02% 161
2017
Q2
$20K Hold
291
0.01% 221
2017
Q1
$20K Sell
291
-761
-72% -$53.5K 0.01% 236
2016
Q4
$76K Buy
1,052
+126
+14% +$9.37K 0.02% 135
2016
Q3
$73K Buy
926
+73
+9% +$5.93K 0.03% 125
2016
Q2
$71K Buy
853
+36
+4% +$3.19K 0.03% 118
2016
Q1
$75K Buy
817
+200
+32% +$18K 0.04% 99
2015
Q4
$62K Buy
+617
New +$64.2K 0.03% 112

Other funds holding GILD

Genovese Burford & Brothers Wealth & Retirement Plan Management's GILD Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 1,692 shares — an estimated $120K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in GILD in Q4 2015 and held it in 10 quarters. The position peaked at $121K in Q1 2018. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 1,692 Gilead Sciences shares in Q3 2018, an estimated $120K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Gilead Sciences in Q4 2015 and held it in 10 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Gilead Sciences position peaked at $121K in Q1 2018.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.